Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-08 | The following table sets forth the compensation awarded or paid to, or earned by, our non-employee directors during 2019: Sean P. Nolan Fees Earned or Paid in Cash: $56,168 Stock Awards: $142,841 Total: $199,009 Audit Committee Robert D. Reed, Chair Melody C. Barnes Sean P. Nolan Walter C. Rakowich |
| 2021-04-13 | Sean P. Nolan is an accomplished senior executive and board member, having served in numerous officer and director positions for privately held and publicly traded companies in the biopharmaceutical industry. He brings to our Board expertise in finance, leadership, management and research and innovation. DIRECTOR SINCE 2019 VTR COMMITTEES Compensation |
| 2023-04-05 | Sean P. Nolan, Independent Director Committees: Compensation Nominating, Governance and Corporate Responsibility 2022 Non-Employee Director Compensation Table: Sean P. Nolan $139,000 Fees Earned or Paid in Cash, $174,956 Stock Awards, Total $313,956 |
| 2024-04-02 | Sean P. Nolan Independent Director Director Since: 2019 Age:56 Committees: Compensation Nominating, Governance and Corporate Responsibility 2023 Non-Employee Director Compensation Table Sean P. Nolan 148,000 174,991 322,991 |
| 2025-04-01 | Sean P. Nolan Independent Director Director Since: 2019 Age: 57 Committees: Compensation Nominating, Governance and Corporate Responsibility Other Current Public Company Directorships: Taysha Gene Therapies, Inc., Chairman of the Board (NASDAQ: TSHA) (since 2020) |
Data sourced from SEC filings. Last updated: 2025-08-30